Manu Ohri
Manu Ohri's purchase track record
Manu Ohri has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/6/2023 | GTBP | $25K | -32.6% | -48.3% | +3.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
GT Biopharma Files Prospectus for Up to 13.5M Shares. GT Biopharma Inc. has filed a prospectus that allows up to 13,502,835 shares of its common stock to be sold by existing shareholders. This filing gives the company and its investors a formal framework for a potential share sale. The prospectus does not change the company’s current operations or financial outlook. Investors can review the details to understand how the sale could affect share supply.
Transaction History
| AXIL | ▲ Buy | Grant | 5,000 | $0 | 1/15/2026 | View on chart |
| AXIL | ▲ Buy | Grant | 5,000 | $0 | 1/13/2025 | View on chart |
| AXIL | ▲ Buy | Grant | 5,000 | $0 | 2/14/2024 | View on chart |
| GTBP | ▲ Buy | Grant | 200,000 | $57K | 8/11/2023 | View on chart |
| GTBP | ▼ Sell | Other | 200,000 | $57K | 8/11/2023 | View on chart |
| GTBP | ▼ Sell | Other | 200,000 | $57K | 8/11/2023 | View on chart |
| GTBP | ▲ Buy | Open Market | 50,000 | $25K | 4/6/2023 | View on chart |
| GTBP | ▼ Sell | Other | 100,000 | $0 | 7/15/2022 | View on chart |
| GTBP | ▲ Buy | Grant | 100,000 | $0 | 7/15/2022 | View on chart |
| GTBP | ▼ Sell | Other | 100,000 | $0 | 7/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
AXIL Brands to Report Q1 FY2027 Earnings on Oct 6
AXIL Brands has announced that it will release its first-quarter fiscal 2027 financial results on October 6, 2026. This upcoming report is the primary catalyst for the stock in the near term, as investors will look for updates on revenue and profitability. The company currently trades with a trailing P/E of 15.7, and the earnings release will provide new data points for valuation.
AXIL Brands to Report Q1 FY2027 Earnings on Oct 6. AXIL Brands has announced that it will release its first-quarter fiscal 2027 financial results on October 6, 2026. This upcoming report is the primary catalyst for the stock in the near term, as investors will look for updates on revenue and profitability. The company currently trades with a trailing P/E of 15.7, and the earnings release will provide new data points for valuation.